The MCF-10A and HMLE cell lines were much less sensitive to the compound than breast cancer cell lines, suggesting that JapA has a selective cytotoxicity for cancer cells and exerts its activity in an MDM2-dependent fashion, regardless of the p53 status. The gene discussed is TP53; the disease is breast cancer.